Form D Explorer
Solius Labs, Inc. · CIK 1537914

Report a data issueCitable research briefCompare issuerPrivate research collection

Solius Labs, Inc.

CIK 1537914 · Corporation · Inc. DELAWARE · BAINBRIDGE ISLAND, Washington · Other Health Care

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
2
Amendments
0
Activity
May 14, 2026
through May 14, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Both filings have the same date. Their sequence is unknown; directional differences are suppressed.

Unavailable values are shown as a dash; reported zero remains zero.
FieldMay 14, 2026 · DMay 14, 2026 · DLater minus earlier
Reported offering amount$23,493,691$17,911,021—
Reported amount sold$23,493,691$3,500,000—
Reported investor count———
Reported minimum investment$0$0—

Earlier SEC source: 0001537914-26-000002 · Later SEC source: 0001537914-26-000003

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · May 14, 2026

Reported offering amount
$17,911,021
Reported exemptions
Rule 506(b)
Reported amount sold
$3,500,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (2)